Back to Search Start Over

Deep brain stimulation as a therapeutic option for obesity: A critical review

Authors :
Bétry, Cécile
Thobois, S.
Laville, M.
Disse, Emmanuel
Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN)
Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon)
Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Institut National de la Recherche Agronomique (INRA)
Service d'Electroneuromyographie et Service de Neurologie C [Hôpital Pierre Wertheimer - HCL]
Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL]
Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL)
Université de Lyon
Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS)
Hospices Civils de Lyon (HCL)
Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon)
Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL)
CarMeN, laboratoire
Source :
Obesity Research & Clinical Practice, Obesity Research & Clinical Practice, 2018, 12 (3), pp.260--269
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

Despite a better understanding of obesity pathophysiology, treating this disease remains a challenge. New therapeutic options are needed. Targeting the brain is a promising way, considering both the brain abnormalities in obesity and the effects of bariatric surgery on the gut-brain axis. Deep brain stimulation could be an alternative treatment for obesity since this safe and reversible neurosurgical procedure modulates neural circuits for therapeutic purposes. We aimed to provide a critical review of published clinical and preclinical studies in this field. Owing to the physiology of eating and brain alterations in people with obesity, two brain areas, namely the hypothalamus and the nucleus accumbens are putative targets. Preclinical studies with animal models of obesity showed that deep brain stimulation of hypothalamus or nucleus accumbens induces weight loss. The mechanisms of action remain to be fully elucidated. Preclinical data suggest that stimulation of nucleus accumbens reduces food intake, while stimulation of hypothalamus could increase resting energy expenditure. Clinical experience with deep brain stimulation for obesity remains limited to six patients with mixed results, but some clinical trials are ongoing. Thus, drawing clear conclusions about the effectiveness of this treatment is not yet possible, even if the results of preclinical studies are encouraging. Future clinical studies should examine its efficacy and safety, while preclinical studies could help understand its mechanisms of action. We hope that our review will provide ways to design further studies. (C) 2018 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Details

Language :
English
Database :
OpenAIRE
Journal :
Obesity Research & Clinical Practice, Obesity Research & Clinical Practice, 2018, 12 (3), pp.260--269
Accession number :
edsair.dedup.wf.001..a3a578986cf46b060dd95f1728736f29